Latest news
September 24, 2010
The Japanese Cancer Association and Debiopharm Group™present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for their outstanding oncology…
September 2, 2010
Professor Leroux from ETH receives the Debiopharm Life Sciences Award 2010
April 8, 2010
Debiopharm Group™ and Biocartis embark on a partnership aiming at enhancing personalized medicine
February 9, 2010
Debiopharm Group™ grants an exclusive licence for the development, manufacture and commercialisation of Debio 025 – A potent, first-in-class antiviral…
February 4, 2010
Launch of Ipsen’s Decapeptyl® 6-month formulation (LP 22.5 mg) in France for the treatment of locally advanced or metastatic hormone-dependent…
January 7, 2010
Pfizer and Debiopharm collaborate to co-develop investigational compound tremelimumab (CP-675,206) in advanced melanoma